👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Pippa Corrie
Oncology
English
12,683+
Patients seen
10
Years in practice
10
Publications
1
Languages spoken
About
Dr. Pippa Corrie qualified in medicine at Oxford University, having already undertaken a PhD in anticancer drug development. She undertook specialist training in Medical Oncology in Birmingham before being appointed as Consultant at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital) in 1996 and subsequently Associate Lecturer at the University of Cambridge. Dr Corrie directed the chemotherapy service at Addenbrooke's Hospital until 2014 and then focused her interests in leading clinical research.
In addition to her clinical work, she is NIHR Lead for Cancer Late Phase and International Trials and CRN Eastern Cancer Specialty Lead. Dr Corrie chaired the NCRI Skin Cancer Clinical Studies Group from 2012-2017 and is a member of the NCRI pancreatic cancer studies subgroup. Dr Corrie has published considerable research. She is the chief investigator of multiple academic and industry-sponsored national and international trials.
Dr. Corrie specialises in pancreaticobilary cancers and cancers of the skin. Her combined expertise in practice and research makes her extremely knowledgable in her field and she provides excellent outcomes for her patients.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Immunotherapy
• Melanoma
• Pancreaticobiliary cancers
• Neuroendocrine cancers
In addition to her clinical work, she is NIHR Lead for Cancer Late Phase and International Trials and CRN Eastern Cancer Specialty Lead. Dr Corrie chaired the NCRI Skin Cancer Clinical Studies Group from 2012-2017 and is a member of the NCRI pancreatic cancer studies subgroup. Dr Corrie has published considerable research. She is the chief investigator of multiple academic and industry-sponsored national and international trials.
Dr. Corrie specialises in pancreaticobilary cancers and cancers of the skin. Her combined expertise in practice and research makes her extremely knowledgable in her field and she provides excellent outcomes for her patients.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Immunotherapy
• Melanoma
• Pancreaticobiliary cancers
• Neuroendocrine cancers
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Pippa Corrie
Education & training
-
2006–2012 MD · Medicine and Surgery
-
2012–2016 Residency · Oncology
Career & appointments
-
2016-09–2017-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AXA Healthcare Liability · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 138 |
| Annual physical exam | 99395 | 2,324 |
| Vaccination administration | 90471 | 484 |
| Minor procedure (skin) | 17110 | 995 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 360.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 11 · i10: 11
-
Validation of clinical scoring in Oncology
DOI: 10.7672/euroclin.2026.0 · PMID: 38945745 · cited by 114
-
Long-term follow-up of Oncology across
DOI: 10.4121/euroclin.2025.1 · PMID: 30879245 · cited by 88
-
Validation of clinical scoring in Oncology
DOI: 10.3497/euroclin.2024.2 · PMID: 32256298 · cited by 62
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2017
- national college of family doctors — Member · since 2017
- European Union of Medical Specialists (UEMS) — Member · since 2017
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · pippa.corrie@euroclinics.example
